Product Pathways - Apoptosis / Autophagy
Phospho-PAR-4 (Thr163) Antibody #2329
PhosphoSitePlus® protein, site, and accession data: PAR-4
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W | H (M) (R) (Mk) | Endogenous | 43 | Rabbit |
Applications Key:
W=Western Blotting
Reactivity Key:
H=Human
M=Mouse
R=Rat
Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.
Protocols
- 2329:
- Western Blotting
Specificity / Sensitivity
Phospho-PAR-4 (Thr163) Antibody detects endogenous levels of PAR-4 when phosphorylated at Thr163 (Thr163 corresponds to human sequence and is equivalent to Thr155 in rat and Thr156 in mouse).
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Thr163 of human PAR-4 (Thr155 in rat and Thr156 in mouse). Antibodies were purified by protein A and peptide affinity chromatography.
Background
PAR-4 (prostate apoptosis response-4) was identified as a protein that is upregulated in prostate tumor cells undergoing apoptosis (1). Additionally, in parallel studies PAR-4 was found in the yeast two-hybrid system to bind to the Wilms' tumor suppressor protein WT1 and may modulate WT1-medated transcriptional activation (2). PAR-4 contains a leucine zipper domain and a death domain and has been implicated as an effector of apoptosis during tumorigenesis as well as in neurodegenerative disorders (3,4). PAR-4 is widely expressed in normal tissues but can be downregulated in some tumor types. The mechanism of PAR-4 mediated apoptosis regulation appears to be complex and dependent on the cellular context. Studies have indicated roles for PAR-4 in activation of the Fas-FADD-caspase-8 pathway as well as inhibition of the NF-κB pro-survival pathway (5-7). Its activity is likely to depend on the cellular context and post-translational modifications. For instance, phosphorylation of PAR-4 by Akt prevents its nuclear translocation thereby promoting cell surivival (8). In contrast, phoshorylation of rat PAR-4 at T155 by PKA appears to positively regulate its apoptotic activity (9).
- Sells, S.F. et al. (1997) Mol. Cell Biol. 17, 3823-3832.
- Johnstone, R.W. et al. (1996) Mol. Cell Biol. 16, 6945-6956.
- Guo, Q. et al. (1998) Nat. Med. 4, 957-962.
- El-Guendy, N. and Rangnekar, V.M. (2003) Exp. Cell Res. 283, 51-66.
- Chakraborty, M. et al. (2001) Cancer Res. 61, 7255-7263.
- Díaz-Meco, M.T. et al. (1996) Cell 86, 777-786.
- Diaz-Meco, M.T. et al. (1999) J. Biol. Chem. 274, 19606-79612.
- Goswami, A. et al. (2005) Mol. Cell 20, 33-44.
- Gurumurthy, S. et al. (2005) Mol. Cell Biol. 25, 1146-1161.
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 2328 PAR-4 Antibody
- 9902 Calyculin A (Serine/Threonine Phosphatase Inhibitor)
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.